Aims: The aim of this study was to identify predictors of adverse events among patients with ST-elevation myocardial infarction (STEMI) undergoing contemporary primary percutaneous corona
Masanori Taniwaki1, MD; Giulio G. Stefanini1, MD; Lorenz Räber1, MD; Salvatore Brugaletta2, MD; Angel Cequier3, MD, PhD; Dik Heg4, PhD; Andrés Iñiguez5, MD, PhD; Henning Kelbæk6, MD; Antonio Serra7, MD, PhD; Miodrag Ostoijic8, MD; Rosana Hernandez-Antolin9, MD, PhD; Andreas Baumbach10, MD; Stefan Blöchlinger1, MD; Peter Jüni4
1. Department of Cardiology, Bern University Hospital, Bern, Switzerland; 2. Department of Cardiology, University Hospital Clinic, Barcelona, Spain; 3. Heart Institute, University Hospital of Bellvitge, Barcelona, Spain; 4. Department of Clinical Research
Sign in to read and download the full articleForgot your password?
No account yet? Sign up for free!Create my pcr account
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
clinical researchpercutaneous coronary interventionprimary angioplastyst-segment elevation myocardial infarction
Read next articleIncidence, predictors, and impact of neurological events in non-ST-segment elevation acute coronary syndromes: the ACUITY trial